Commodore Capital LP 13D and 13G filings for Adverum Biotechnologies, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 4:05 pm Purchase |
2023-12-31 | 13G | Adverum Biotechnologies, Inc. ADVM |
Commodore Capital LP | 1,000,000 9.900% |
384,186 (+62.39%) |
Filing |
| 2023-04-20 4:05 pm Purchase |
2023-04-10 | 13G | Adverum Biotechnologies, Inc. ADVM |
Commodore Capital LP | 615,814 6.100% |
615,814 (New Position) |
Filing |